Pdt Partners, LLC Talis Biomedical Corp Transaction History

Pdt Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.3 - $4.19 $45,357 - $146,189	-34,890 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.17 $18,215 - $29,498	4,781 Added 15.88%	34,890 $140,000
Q3 2021 Nov 15, 2021	BUY	$6.02 - $12.46 $181,256 - $375,158	30,109 New	30,109 $188,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $231M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.